
Please try another search
Zentiva, a.s. develops, manufactures, and sells generic medicinal products, primarily used in primary care sector in Slovak, Czech Republic, and internationally. The company offers prescription medicines. It also engages in the production and wholesaling of pharmaceuticals and chemical products. The company sells 56 pharmaceutical forms in Slovakia. Its portfolio includes lipid lowering agaents, hypothensive, sympatholytic, prokinetics, vitamins, antipyretics, beta- blockers, otorinolaryngol, antidiabetics, and anthistamines products. The company was formerly known as Slovakofarma, a.s. and changed its name to Zentiva, a.s. in 2003. Zentiva, a.s. was incorporated in 1992 and is based in Bratislava, Slovakia.
Name | Age | Since | Title |
---|---|---|---|
Mojmir Kruty | - | 2013 | Member of Supervisory Board |
Helena Kopkova | - | 2011 | Chairwoman of the Supervisory Board |
Mehdi Patrick Lahnech | - | 2015 | Director |
Nicolas Enrique Macciavello | - | 2015 | Director |
Thomas Cornelis Koene | - | 2015 | Chairman of the Board of Directors & Head of Technical Operations |
Eric Richard Le Bris | - | 2015 | Member of Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review